175 related articles for article (PubMed ID: 17200364)
1. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Fishel ML; He Y; Smith ML; Kelley MR
Clin Cancer Res; 2007 Jan; 13(1):260-7. PubMed ID: 17200364
[TBL] [Abstract][Full Text] [Related]
2. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
[TBL] [Abstract][Full Text] [Related]
3. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.
Rinne M; Caldwell D; Kelley MR
Mol Cancer Ther; 2004 Aug; 3(8):955-67. PubMed ID: 15299078
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha.
Yan L; Bulgar A; Miao Y; Mahajan V; Donze JR; Gerson SL; Liu L
Clin Cancer Res; 2007 Mar; 13(5):1532-9. PubMed ID: 17332299
[TBL] [Abstract][Full Text] [Related]
5. Base excision repair as a therapeutic target in colon cancer.
Liu L; Nakatsuru Y; Gerson SL
Clin Cancer Res; 2002 Sep; 8(9):2985-91. PubMed ID: 12231545
[TBL] [Abstract][Full Text] [Related]
6. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.
Agnihotri S; Burrell K; Buczkowicz P; Remke M; Golbourn B; Chornenkyy Y; Gajadhar A; Fernandez NA; Clarke ID; Barszczyk MS; Pajovic S; Ternamian C; Head R; Sabha N; Sobol RW; Taylor MD; Rutka JT; Jones C; Dirks PB; Zadeh G; Hawkins C
Cancer Discov; 2014 Oct; 4(10):1198-213. PubMed ID: 25100205
[TBL] [Abstract][Full Text] [Related]
7. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
[TBL] [Abstract][Full Text] [Related]
8. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
[TBL] [Abstract][Full Text] [Related]
9. Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.
Taverna P; Liu L; Hwang HS; Hanson AJ; Kinsella TJ; Gerson SL
Mutat Res; 2001 May; 485(4):269-81. PubMed ID: 11585361
[TBL] [Abstract][Full Text] [Related]
10. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide.
Montaldi AP; Sakamoto-Hojo ET
Clin Exp Med; 2013 Nov; 13(4):279-88. PubMed ID: 22828727
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
[TBL] [Abstract][Full Text] [Related]
12. Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
Tentori L; Turriziani M; Franco D; Serafino A; Levati L; Roy R; Bonmassar E; Graziani G
Leukemia; 1999 Jun; 13(6):901-9. PubMed ID: 10360379
[TBL] [Abstract][Full Text] [Related]
13. N-methylpurine DNA glycosylase inhibits p53-mediated cell cycle arrest and coordinates with p53 to determine sensitivity to alkylating agents.
Song S; Xing G; Yuan L; Wang J; Wang S; Yin Y; Tian C; He F; Zhang L
Cell Res; 2012 Aug; 22(8):1285-303. PubMed ID: 22801474
[TBL] [Abstract][Full Text] [Related]
14. Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.
Fishel ML; Seo YR; Smith ML; Kelley MR
Cancer Res; 2003 Feb; 63(3):608-15. PubMed ID: 12566303
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase.
Barvaux VA; Lorigan P; Ranson M; Gillum AM; McElhinney RS; McMurry TB; Margison GP
Mol Cancer Ther; 2004 Oct; 3(10):1215-20. PubMed ID: 15486188
[TBL] [Abstract][Full Text] [Related]
16. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
[TBL] [Abstract][Full Text] [Related]
17. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
18. Alkylation sensitivity screens reveal a conserved cross-species functionome.
Svilar D; Dyavaiah M; Brown AR; Tang JB; Li J; McDonald PR; Shun TY; Braganza A; Wang XH; Maniar S; St Croix CM; Lazo JS; Pollack IF; Begley TJ; Sobol RW
Mol Cancer Res; 2012 Dec; 10(12):1580-96. PubMed ID: 23038810
[TBL] [Abstract][Full Text] [Related]
19. Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components.
Tentori L; Portarena I; Vernole P; De Fabritiis P; Madaio R; Balduzzi A; Roy R; Bonmassar E; Graziani G
Cancer Chemother Pharmacol; 2001 Apr; 47(4):361-9. PubMed ID: 11345654
[TBL] [Abstract][Full Text] [Related]
20. Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells.
Chen M; Osman I; Orlow SJ
Mol Cancer Res; 2009 May; 7(5):703-12. PubMed ID: 19435820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
